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1. Introduction 
A new aspect of immunoglobulin (lg) synthesis has 
emerged from recent experiments employing lg light 
chain messenger RNAs from mouse plasmacytomas in 
cell-free protein synthesizing systems. lg light chain 
mRNAs from at least six different plasmacytomas, 
including those synthesizing either K or X2 light chains, 
direct the cell-free synthesis of a polypeptide variously 
estimated to be 740-4700 daltons larger than the 
corresponding light chain [l-6] . These larger cell-free 
products, designated here as P chains [ 1 ] , possess 
extra amino acid residues preceding the normal 
amino-terminus of the light chain [ 1,4] . It seems 
unlikely that P chains are merely artifacts of cell-free 
translation since other eukaryotic mRNAs are 
faithfully translated by the same cell-free systems 
[7-91. Furthermore, three different cell-free systems 
all synthesize a P chain of the same size in response to 
an individual K or h2 light chain mRNA ([6] and 
manuscript in preparation). It has been suggested that 
P chain is a precursor to lg light chain [l-3] , but no 
precursor-product relationship has yet been demon- 
strated nor has an intracellular precursor polypeptide 
been found. 
We report here that MOPC 41 A plasmacytoma cells 
in the presence of an inhibitor of proteolytic enzymes 
synthesize a polypeptide which appears to be equivalent 
to P chain made in cell-free systems. 
2. Experimental 
The protease inhibitors used (from Calbiochem) 
were TLCK (N-cu-tosyl-L-lysyl chloromethane, hydro- 
North-Holland Publishing Company -Amsterdam 
chloride), a trypsin inhibitor [lo] , TPCK (tosyl-L- 
phenylalanyl-chloromethane), a chymotrypsin inhibitor 
[lo] , and TAME (@-toluene sulphonyl-L-arginine 
methyl ester, hydrochloride) [ 111. Stock solutions 
(in ethanol) were respectively 25 mg/ml, 5 mg/ml, and 
44 mg/ml. 
The murine plasmacytoma lines used in this study 
and their secreted immunoglobulins are (for ref. see 
[6] ): MOPC 41 A, light chain (K); MOPC 3 15, IgA 
(X2); P3K, IgCl (K); HPC-108, IgA (K); and MPC 11, 
lgC2b (K) [ 121. MOPC 41 A was maintained as a 
subcutaneous solid tumour in BALB/c mice; before 
each experiment a small tumour (l--2 g) was dispersed 
into a cell suspension, damaged cells were removed [ 131 
and the cells cultured for about 20 hr at 4&6 X 10’ per 
ml in DME (Dulbecco’s modified Eagle’s medium from 
GIBCO) supplemented with 20% heat-inactivated 
horse serum (Laboratory Services, Sydney). The other 
lines were maintained in cell culture in DME supple- 
mented with 10% heat-inactivated foetal calf serum 
(Commonwealth Serum Laboratories, Melbourne). 
Prior to labelling, cells were washed in methionine- 
free DME (C.S.L., Melbourne), resuspended at 
2-10 X lo6 per ml in the same medium, and dispensed 
into plastic tubes (0.9 ml/tube). Up to 20 ~1 protease 
inhibitor was added to appropriate tubes; the final 
concentrations tested were TLCK, 50-250 pg/ml; 
TPCK, lo-100 pg/ml; TAME, 875 pg/ml. After 2 min 
at 37”C, [3”S] methionine (Amersham 25-40 mCi/pmol) 
was added to a final concentration of 1.4-2.0 PM and 
the tubes were incubated for up to 30 min at 37°C. 
The tubes were then chilled rapidly and 0.5 ml crushed 
frozen buffer (150 mM NaCl, 1.5 mM Mg(CH3 COO)Z, 
10 mM Tris-Cl, pH 7.2) was added to each. All 
subsequent procedures were at 0-4°C. The cells were 
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sedimented and resuspended at 4 X 1 O6 per ml in lysis 
buffer (0.5% Nonidet P-40,250 pg/ml TLCK, 50 pg/ml 
TPCK, 150 mM NaCl, 1.5 mM Mg(CHsC00)2, 10 mM 
Tris-Cl, pH 7.2); five min later nuclei were removed 
by sedimentation (1400 g, 3.5 min) and the post- 
nuclear supernatant was used for subsequent analyses. 
Ig chains in post-nuclear supernatants (20-l 50 ~1) 
were precipitated with antisera (40- 150 ~1); the final 
immunoprecipitation mixtures were adjusted to 500 yl 
with phosphate-buffered saline (120 mM NaCl, 16 mM 
Na2HP04, 4 mM NaH2P04) and contained 3% Triton 
X-l 00. After at least 3 hr at 2°C the immunoprecipitates 
were washed 2-3 times by centrifugation (8000 g, 
20 min) in the same buffer, then dissolved in 
electrophoresis ample buffer [ 141. The antisera used 
were prepared from rabbits immunized with purified 
HPC-108 K chain (anti-k serum) or with purified 
MOPC 3 15 IgA (X2) (anti-IgA (h2) serum). 
The size of polypeptides synthesized by MOPC 41 A 
cells in the presence or absence of the inhibitor TLCK 
can be seen in fig. 1. Since MOPC 41 A does not 
synthesize a heavy chain, the most prominent product 
in the post-nuclear supernatant from untreated cells is 
Ig light chain (L, gel l), identified by its size, specific 
precipitation by anti-K serum (L, gel 6), and comigration 
with secreted MOPC 41A K chain. The untreated cells 
appeared to contain no immunoprecipitable polypeptide 
larger than L chain (gel 6), even after an autoradio- 
graphic exposure three times longer than that shown. 
The precise mobility expected for the P chain was 
determined by adding MOPC 41 A P chain synthesized 
in a cell-free system [6] to other control samples prior 
to electrophoresis (P, gels 2 and 7). Cells labelled in the 
1A 
Labelled polypeptides in post-nuclear supernatants 
or in immunoprecipitates were analyzed by electro- 
phoresis on 15% polyacrylamide gels containing SDS 
[ 141 and the gels were stained, sliced, dried and 
autoradiographed for l-4 weeks [ 151. 
presence of 50, 125 or 250 pg/ml TLCK, however, 
yielded a new polypeptide (P, gels 3-5) which had 
exactly the same mobility as the reference MOPC 4 
P chain and which was precipitable by anti-K serum 
(gels 8- 10). At the highest concentration of TLCK 
used, there was about twice as much of this poly- 
peptide as there was light chain. 
3. Results 
In initial attempts to detect intracellular P chain, 
we labelled MOPC 41 A cells with a pulse of 
[ 35S] me thionine (1~ 10 min) and used SDS gel 
electrophoresis [ 141 to analyze the size of newly 
synthesized polypeptides precipitable by an anti+ 
serum. Although L chain was a very prominent 
product, we failed to detect any immunoprecipitable 
polypeptide the size of MOPC 41 A P chain, which is 
2000 daltons larger than the L chain ([6] and 
manuscript in preparation). This suggested that if 
intracellular P chain exists it must be very short lived. 
The new polypeptide was detected only when the 
inhibitor was present during the incorporation of 
[3sS] methionine; addition of TLCK at the time of 
cell lysis was not sufficient. The intracellular P chain 
has been detected in five experiments with TLCK, 
despite a substantial depression of total protein 
synthesis caused by the inhibitor (see also [ 171. 
TLCK was the only inhibitor tested which consistently 
revealed the new polypeptide in MOPC 41 A cells. With 
TAME, it was not detected; with TPCK the new 
polypeptide was fountl in one experiment but not in a 
second. In some experiments with TLCK, a faint band 
between P chain and L chain was seen (see fig.1 gel 4) 
but whether this is due to extraneous proteolysis or to 
a processing mechanism involving more than one 
proteolytic event is not known. 
Since any cellular mechanism for converting We have not yet detected any immunoprecipitable 
P chain to light chain would include at least one polypeptide with the mobility of a P chain in cells of 
proteolytic event, the processing mechanism might be the four other plasmacytoma lines tested. No new 
sensitive to inhibitors of proteolytic enzymes. Such polypeptides were observed in P3K, MPC 1 1, or HPC- 
agents have been used to reveal the existence of 108 cells labelled in the presence of any of the 
transient viral polypeptide precursors inside cells inhibitors. MOPC 3 15 cells during a 30 min incubation 
[16,17] . We therefore attempted to detect P chain in in the presence of TLCK, TPCK or TAME synthesized 
the plasmacytoma cells during a 30 min incubation a new polypeptide, about 900 daltons larger than 
with [3sS]methionine in the presence of three protease MOPC 3 15 Ig light chain, which appears to be 
inhibitors. precipitable with anti-IgA (h2) serum. However, this 
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Fig.1. Electrophoretic analysis on SDS acrylamide gels of polypeptides synthesized by MOPC 41A cells in the presence or absence 
of TLCK. The cells were incubated for 30 min with [“S] methionine and the indicated concentrations of TLCK. MOF’C 41A P 
chain synthesized in a wheat germ cell-free system [6] was added to samples from untreated cells in gels 2 and 7. To compensate 
for the reduced total protein synthesis in the TLCK-treated cultures, up to twice as much post nuclear supernatant from treated 
cultures was used for analysis. The molecular weight scale is based upon the mobilities of a set of ‘*51-labelled polypeptides of 
known mol. wt run on a parallel gel (61. 
product was smaller than the MOPC 3 15 P chain, 
which has an apparent mol. wt of 2200 greater than 
MOPC 3 15 light chain ( [6] and manuscript in 
preparation). 
4. Discussion 
We have shown here that MOPC 41 A plasmacytoma 
cells in the presence of the proteolytic inhibitor TLCK 
synthesize a new polypeptide serologically related to 
Ig light chain. This polypeptide is exactly the same 
size as the MOPC 41 A P chain synthesized in three 
different cell-free translating systems programmed 
with MOPC 4 1 A light chain mRNA ( [3,6] and 
manuscript in preparation). This demonstration of an 
intracellular P chain supports the argument that the 
polypeptide formed in the cell-free systems is not an 
artifact and considerably strengthens the case that P 
chain is a biosynthetic precursor to the light chain. 
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The effect of TLCK presumably is due to its ability to 
inhibit some trypsin-like processing activity, although 
we have no direct evidence for this. The absence of 
detectable P chain in pulse-labelled MOPC 41 A cells 
not treated with TLCK may indicate that the extra 
amino acid residues in P chain are normally excised 
either before or very shortly after synthesis of the 
chain has been completed. 
The lack of demonstrable intracellular P chain in 
four other plasmacytoma cell lines is somewhat 
surprising, although there are many possible explanations, 
such as differences between cell lines in inhibitor uptake, 
in non-specific proteolysis after lysis, or in sensitivity 
of processing enzymes to inhibition. Moreover, 
MOPC 41 A may have been particularly favorable for 
these studies since 30% of the protein synthesized by 
the cells of this tumour line is lg light chain compared 
to 2%4% in the four other cell lines (A. Harris, 
unpublished results). 
Several other proteins are known to be synthesized 
as larger precursors, including collagen [ 181 , rat serum 
albumin [ 191, and some hormones (eg. insulin and 
parathyroid hormone) [20]. The cell-free translation 
product of parathyroid hormone mRNA is even 
larger than the known prohormone and is apparently 
a very transient molecule [21] , like Ig P chain. 
Perhaps all proteins made on membrane-bound 
polysomes are normally synthesized as larger poly- 
peptides, which are then reduced in size during or 
after transport across the microsomal membrane. 
Recent experiments with HeLa cells grown in the 
presence of TPCK [22] suggest hat transient larger 
precursors may occur during the biosynthesis of many 
proteins. 
The function of the extra residues on Ig P chain is 
still obscure (see [ 1,23,24]). They could be involved in 
ensuring translation of Ig light chain mRNA on 
membrane-bound polysomes, in assembling intracellu- 
lar Ig, or in transporting newly synthesized polypeptide 
across the microsomal membrane. 
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